Small Molecule Therapy for SMA

Dr. Charlotte Sumner describes small molecule therapies for SMA.

Now, one of the basic types of strategies has been to try and find small molecules, drugs, that activate the expression of the gene at the gene level. So each gene is controlled in its expression pattern by upstream genetic sequence what we call a promoter and that promoter is sometimes more active, sometimes less active. But the idea of drugs to increase SMN expression at the gene level has been to try and find drugs that would activate the promoter of the gene. And there have been numerous efforts to find such molecules. Years ago, there was an observation that a kind of drug called an HDAC inhibitor, a histone deacetylase inhibitor could activate gene expression. The trouble with HDAC inhibitors in general is they're a fairly toxic kind of drug. Another drug that works in this same way presumably is what we call the quinazolines. So this is another drug that was discovered that could increase SMN expression at presumably the promoter level.

Spinal muscular atrophy, SMA, RNA, mRNA, splicing, gene, genetic, DNA, antisense, motor neuron, splice, Therapy, Molecule, expression, promoter, SMN, HDAC inhibitor, quinazolines, Hopkins, john Hopkins, transcription, exon 7

Related Content

16950. 2D Animation of Antisense Oligonucleotide Therapy for SMA

An animation shows how antisense oligonucleotide therapy for SMA utilizes RNA splicing.

  • ID: 16950
  • Source: DNALC.SMA

16948. Alternative RNA Splicing Therapy for Spinal Muscular Atrophy

Drs. Sharp and Sumner describe how RNA splicing can be used as a therapy for SMA.

  • ID: 16948
  • Source: DNALC.SMA

16941. 2D Animation of Alternative RNA Splicing

An animation shows alternate splicing of the SMN2 gene.

  • ID: 16941
  • Source: DNALC.SMA

16910. Cause of SMA

Dr. Sumner explains what causes SMA.

  • ID: 16910
  • Source: DNALC.SMA

16946. An Overview of Future Therapies for SMA

Dr. Sumner provides an overview of targets for SMA therapies.

  • ID: 16946
  • Source: DNALC.SMA

16935. The Connection Between SMA and RNA Splicing

Dr. Krainer explains the connection between SMA and RNA splicing.

  • ID: 16935
  • Source: DNALC.SMA

16949. Antisense Oligonucletotide Therapy for SMA

Dr. Krainer explains the science behind antisense therapy for SMA.

  • ID: 16949
  • Source: DNALC.SMA

16953. Gene Therapy for SMA

Dr. Sumner talks about gene therapy for SMA.

  • ID: 16953
  • Source: DNALC.SMA

16929. Genes Involved with SMA

Dr. Sumner explains how SMA is related to changes in the SMN1 and SMN2 genes.

  • ID: 16929
  • Source: DNALC.SMA

16911. A simple description of the cause of SMA

Frank, an SMA parent, describes the genetics of SMA.

  • ID: 16911
  • Source: DNALC.SMA